The top 5 studies from July 2019

OB Hospitalist Group has released data indicating disparities in maternal care because patient race is reduced by care from obstetric hospitalists.

In this episode of Pap Talk, Contemporary OB/GYN® sat down with Maneesh Jain, CEO of Mirvie, and Michal Elovitz, MD, chief medical advisor at Mirvie, a new RNA platform that is able to predict pregnancy complications by revealing the biology of each pregnancy. They discussed recently published data regarding the platform's ability to predict preeclampsia and preterm birth.

The Supreme Court will make a decision on whether restrictions on mifepristone (Mifeprex; Danco Laboratories) should pass by Friday night.

Halley Crissman, MD, MPH, and Daphna Stroumsa, MD, MPH, MSC, discuss ways in which ob/gyns can provide high-quality care for transgender and nonbinary people assigned female sex at birth.

Following voluntary market withdrawal from Covis Pharma, the FDA has decided to withdraw the approval of Makena and its generics for reducing the risk of preterm birth.

For preterm infants, clinical outcomes from microbial mechanisms are not affected by a diet of only human milk compared to bovine milk formulas or fortifiers.